Mivtachim The Workers Social Insurance Fund Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$85.7M |
| 2 |
Viatris
VTRS
|
+$4.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$6.49M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.47M |
| 3 |
Perrigo
PRGO
|
+$4.2M |
| 4 |
Opko Health
OPK
|
+$3.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.43% |
| 2 | Utilities | 2.61% |
| 3 | Technology | 0.95% |
| 4 | Consumer Discretionary | 0.8% |
Similar funds
Mivtachim The Workers Social Insurance Fund's Q3 2017 Portfolio in Review
As of Q3 2017, Mivtachim The Workers Social Insurance Fund held 13 positions worth $1.59B, up 5.4% from $1.51B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Mivtachim The Workers Social Insurance Fund deployed $71.4M of net new capital in Q3 2017, opening 2 new positions and adding to 2 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 6.4% of assets, down from 8.4% a quarter earlier, followed by Utilities and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.47M trimmed.
- Mivtachim The Workers Social Insurance Fund added most to Vanguard Real Estate ETF in Q3 2017, an estimated $85.7M increase.
- Mivtachim The Workers Social Insurance Fund's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.47M.
- Mivtachim The Workers Social Insurance Fund fully exited Teva Pharmaceuticals in Q3 2017, selling an estimated $6.49M.
- Mivtachim The Workers Social Insurance Fund's ten largest holdings make up 100% of its $1.59B portfolio in Q3 2017.
- Mivtachim The Workers Social Insurance Fund opened 2 new positions and closed 1 in Q3 2017.
- Mivtachim The Workers Social Insurance Fund's portfolio value rose 5.4% quarter-over-quarter to $1.59B.
Based on Mivtachim The Workers Social Insurance Fund's 13F filing for Q3 2017, filed 1 Nov 2017.